The long-awaited federal ZEV sales mandate for light-duty vehicles will require auto makers and importers to meet ZEV sales quotas aligned with federal targets — 20 per cent in 2026, 60 per cent in 2030 and 100 per cent in 2035.
SpaceX is aiming to launch another batch of Starlink v2 Mini satellites from the Space Launch Complex 40 launchpad. This Booster, B1058, will try to launch and land for a record-breaking 19th time.\
\
Window Opens: December 22nd at 11PM EST (04:00 UTC on the 23rd)\
Window Closes: December 23rd at 3:31AM EST (08:31 UTC)\
Primary T0: December 22nd at 11:00PM EST (04:00 UTC on the 23rd)\
\
Mission: F9 launch of 23 Starlink v2 Mini satellites \
Target orbit: 285km perigee, 293km apogee, 43 degree inclination.\
Booster: B1058-19; 49d 3h 22min 40s turnaround\
Booster history: Demo-2, Anasis II, SL v1.0–12, CRS-21, Transporter-1, SL v1.0–20, SL v1.0–23, SL v1.0–26, SL 4–1, Transporter-3, SL 4–8, SL 4–17, SL 4–21, SL 4–2, SL 4–37, SL 6–5, SL 6–17, SL 6–26.\
Booster recovery: Droneship Just Read The Instructions (JRIT) located 629km downrange\
Fairing recovery: Bob\
Rocket trajectory: Southeast passing north of Bahamas\
Stubby nozzle: NO\
Stats: \
· SpaceX’s 95th launch of the year and the 6th launch of the month\
· 262nd Falcon orbital launch since Amos 6, F9’s 282nd orbital flight.\
· SpaceX’s 161st launch from SLC-40\
· 71st landing on JRTI out of 72 attempts\
· 181st successful landing since the last failed one\
· 55th launch dedicated to Starlink Gen 2 and 129th launch dedicated to Starlink overall.\
· First Falcon booster to fly for a 19th time\
\
Forum: https://forum.nasaspaceflight.com/ind…\
\
⚡ Become a member of NASASpaceflight’s channel for exclusive discord access, fast turnaround clips, and other exclusive benefits. Your support helps us continue our 24/7 coverage. ⚡\
\
🔍 If you are interested in using footage captured by this stream, please review our content use policy: https://www.nasaspaceflight.com/conte…
Breast cancer is the most common type of cancer and it is treated with surgical intervention, radiotherapy, chemotherapy, or a combination of these regimens. Despite chemotherapy’s ample use, it has limitations such as bioavailability, adverse side effects, high-dose requirements, low therapeutic indices, multiple drug resistance development, and non-specific targeting. Drug delivery vehicles or carriers, of which nanocarriers are prominent, have been introduced to overcome chemotherapy limitations. Nanocarriers have been preferentially used in breast cancer chemotherapy because of their role in protecting therapeutic agents from degradation, enabling efficient drug concentration in target cells or tissues, overcoming drug resistance, and their relatively small size. However, nanocarriers are affected by physiological barriers, bioavailability of transported drugs, and other factors.
As the prominence of Artificial Intelligence (AI) continues to rise in our society, so do the concerns about its implications. Therefore, addressing these fears requires a multi-faceted approach, combining careful design, transparent practices, robust regulation, and thoughtful ethical guidelines.
Below is a list of 20 potential effects AI could have on society, concerns raised by many, and how they could or are currently being overcome.
Ultimately, the goal is to navigate the AI-driven future responsibly, building a society where technology serves human needs effectively and ethically.
A multi-university team of researchers, supported by federal funding, is developing a highly efficient bacterial therapeutic to target cancer more precisely to make treatment safer through a single $1 dose.
Traditionally, cancer therapies have been limited in their efficacy in treating patients. Some, like radiation and chemotherapy, cause harmful side effects, while others tend to result in low patient responsiveness, not to mention the cost it takes to receive treatment. Findings from the American Cancer Society Cancer Action Network recorded that 73% of cancer survivors and patients were worried about how they were going to pay the cost of their cancer care, and 51% said they were in medical debt from treatment. For example, state-of-the-art cancer therapy can cost up to $1,000,000.
Texas A&M University and the University of Missouri are leading the effort to develop a low-cost, safe, and controlled cancer treatment. Researchers received a $20 million grant from the Advanced Research Projects Agency for Health (ARPA-H) to fight cancer. The four-year project is part of the current administration’s Cancer Moonshot initiative, an effort to advance and increase funding for cancer research. It is one of the first projects funded by the newly established agency that aims to accelerate better health outcomes for everyone by supporting the development of high-impact solutions to society’s most challenging health problems.
Google’s AI GNoME has predicted 2.2 million novel inorganic crystal structures. If synthesized in labs, they may pave the way for new technologies.
A group of researchers in Japan have found yet another interesting way to use AI technology. In a recent research project led by a team from the National Institutes for Quantum Science and Technology (QST) and Osaka University, they were able to translate human brain activity to depict mental images of objects, animals, and landscapes. They released pictures from the research, and the results are pretty astounding.
One of the images that the AI technology was able to decode from the brain activity was a vivid depiction of a leopard with detailed features like spots, ears, and more. Another image depicted an airplane. While we have previously had technology that is able to recreate images from brain activity, this is one of the very few studies that were able to make these mental images visible.
Of these previous studies, the images that could be decoded were fairly limited into several categories, like human faces, letters, and numbers. This new AI brain-decoding technology seems to be able to decode a much broader spectrum of images from the human mind. As the researchers in the study point out, “visualizing mental imagery for arbitrary natural images stands as a significant milestone.”
Quanta Magazine’s full list of the major computer science discoveries from 2023.
In 2023, artificial intelligence dominated popular culture — showing up in everything from internet memes to Senate hearings. Large language models such as those behind ChatGPT fueled a lot of this excitement, even as researchers still struggled to pry open the “black box” that describes their inner workings. Image generation systems also routinely impressed and unsettled us with their artistic abilities, yet these were explicitly founded on concepts borrowed from physics.
The year brought many other advances in computer science. Researchers made subtle but important progress on one of the oldest problems in the field, a question about the nature of hard problems referred to as “P versus NP.” In August, my colleague Ben Brubaker explored this seminal problem and the attempts of computational complexity theorists to answer the question: Why is it hard (in a precise, quantitative sense) to understand what makes hard problems hard? “It hasn’t been an easy journey — the path is littered with false turns and roadblocks, and it loops back on itself again and again,” Brubaker wrote. “Yet for meta-complexity researchers, that journey into an uncharted landscape is its own reward.”
ICYMI: In a groundbreaking achievement, researchers have successfully created a chimeric monkey with two different sets of DNA through the injection of stem cells from one monkey embryo into another of the same species.
[Source]
Scientists based in China have successfully created a chimeric monkey.
How they did it: A chimera is a human or an animal whose body is composed of cells that are genetically distinct. For their study, the researchers used two sets of DNA: stem cells from a cynomolgus (crab-eating macaque) monkey and a genetically distinct four-to five-day-old embryo from the same species. After implanting embryos into 40 female macaques, they recorded 12 pregnancies and six live births.
For many people struggling with obesity, the drug is a potential lifesaver. Excess weight is associated with higher incidences of stroke, heart and liver disease, sleep apnea, joint problems, and some cancers. A major clinical trial this year in tens of thousands of overweight people without diabetes found the main ingredient in Ozempic, semaglutide, reduced the risk of stroke and heart attack, while lowering the chances of death due to cardiovascular problems.
Perhaps even more importantly, the drug is gradually changing societal views on obesity—it’s not due to lack of will power, but a chronic medical condition that can be treated.
But Ozempic and similar drugs—like Wegovy, another semaglutide-based medication that has been FDA-approved for weight loss—are already set for the next chapter: tackling a wide range of brain disorders, including Alzheimer’s and Parkinson’s. Clinical trials are underway for addiction, and the drugs are showing early promise battling bipolar disorder and depression.